Serum cartilage oligomeric matrix protein (COMP) levels in knee osteoarthritis in a Brazilian population: clinical and radiological correlation

References

• Saxne T., Heinegard D. Cartilage oligomeric matrix protein: a novel marker of cartilage turnover detectable in synovial fluid and blood. Br J Rheumatol 1992; 31: 583–91
   PubMedGoogle Scholar
• Neidhart M., Hauser N., Paulsson M., DiCesare P. E., Michel B. A., Hauselmann H. J. Small fragments of cartilage oligomeric matrix protein in synovial fluid and serum as markers for cartilage degradation. Br J Rheumatol 1997; 36: 1151–60
   PubMedGoogle Scholar
• Salminen‐Mankonen H., Saamanen A. M., Jalkanen M., Vuorio E., Pirila L. Syndecan‐1 expression is upregulated in degenerating articular cartilage in a transgenic mouse model for osteoarthritis. Scand J Rheumatol 2005; 34: 469–74
   PubMed Web of Science ®Google Scholar
• Vergunst C. E., van de Sande M. G., Lebre M. C., Tak P. P. The role of chemokines in rheumatoid arthritis and osteoarthritis. Scand J Rheumatol 2005; 34: 415–25
   PubMed Web of Science ®Google Scholar
• Oldberg A., Antonsson P., Lindblom K., Heinegard D. COMP (cartilage oligomeric matrix protein) is structurally related to the thrombospoidins. J Biol Chem 1992; 267: 22346–50
   PubMed Web of Science ®Google Scholar
• Hedbom E., Antonsson P., Hjerpe A., Aeschlimann A., Paulsson M., Rosa‐ Pimentel E., et al. Cartilage matrix proteins. An acidic oligomeric protein (COMP) detected only in cartilage. J Biol Chem 1992; 267: 6132–6
   PubMed Web of Science ®Google Scholar
• Muller G., Michel A., Altenburg E. COMP (cartilage oligomeric matrix protein) is synthesized in ligament, tendon, meniscus and articular cartilage. Connect Tissue Res 1998; 39: 233–44
   PubMed Web of Science ®Google Scholar
• Lohmander L. S., Saxne T., Heinegard D. K. Release of cartilage oligomeric matrix protein (COMP) into joint fluid after knee injury and in osteoarthritis. Ann Rheum Dis 1994; 53: 8–13
   PubMed Web of Science ®Google Scholar
• Bleasel J. F., Poole A. R., Heinegard D., Saxne T., Holderbaum D., Ionescu M., et al. Changes in serum cartilage markers levels indicate altered cartilage metabolism in families with osteoarthritis‐related type II collagen gene COL2A1 mutation. Arthritis Rheum 1999; 42: 39–45
   PubMed Web of Science ®Google Scholar
• Vilim V., Vencovsky J. Cartilage oligomeric matrix protein (COMP) is present in synovium from patients with osteoarthritis and rheumatoid arthritis. Trans Orthop Res Soc 1997; 22: 473
   Google Scholar
• Forslind K., Eberhardt K., Jonsson A., Saxne T. Increased serum concentrations of cartilage oligomeric matrix protein. A prognostic marker in early rheumatoid arthritis. Br J Rheumatol 1992; 31: 593–8
   PubMedGoogle Scholar
• Mansson B., Carey D., Alini M., Ionescu M., Rosenberg L. C., Poole A. R. Cartilage and bone metabolism in rheumatoid arthritis: differences between rapid and slow progression of disease by serum markers of cartilage metabolism. J Clin Invest 1995; 95: 1071–7
   PubMed Web of Science ®Google Scholar
• Skoumal M., Kolarz G., Klingler A. Serum levels of cartilage oligomeric matrix protein. A predicting factor and a valuable parameter for disease management in rheumatoid arthritis. Scand J Rheumatol 2003; 32: 156–61
   PubMed Web of Science ®Google Scholar
• Sharif M., Saxne T., Shepstone L., Kirwan J. R., Elson C. J., Heinegard D., et al. Relationship between serum cartilage oligomeric protein levels and disease progression in osteoarthritis of knee joint. Br J Rheumatol 1995; 34: 306–10
   PubMedGoogle Scholar
• Vilim V., Olejarova M., Machacek S., Gatterova J., Kraus V. B., Pavelka K. Serum levels of cartilage oligomeric matrix protein (COMP) correlate with radiographic progression of knee osteoarthritis. Osteoarthritis Cartilage 2002; 10: 707–13
   PubMed Web of Science ®Google Scholar
• Conrozier T., Saxne T., Fan C. S., Mathieu P., Tron A. M., Heinegard D., et al. Serum concentrations of cartilage oligomeric matrix protein and bone sialoprotein in hip osteoarthritis: a one year prospective study. Ann Rheum Dis 1998; 57: 527–32
   PubMed Web of Science ®Google Scholar
• Clark A. G., Jordan J. M., Vilim V., Renner J. B., Dragomir A. D., Luta G., et al. Serum cartilage oligomeric matrix protein reflects osteoarthritis presence and severity: the Johnton County Osteoarthritis Project. Arthritis Rheum 1999; 42: 2356–64
   PubMed Web of Science ®Google Scholar
• Jordan J. M., Luta G., Stabler T., Renner J. B., Dragomir A. D., Vilim V., et al. Ethnic and sex differences in serum levels of cartilage oligomeric matrix protein: the Johnton County Osteoarthritis Project. Arthritis Rheum 2003; 48: 675–81
   PubMed Web of Science ®Google Scholar
• Lequesne M., Mery C., Samson M., Gerard P. Indices of severity for osteoarthritis of the hip and the knee. Validation‐value in comparison with the other assessment tests. Scand J Rheumatol 1987; 16((Suppl 65))85–9
   Google Scholar
• Bellamy N., Buchanan W. W., Goldsmith C. H., Campbell J., Stitt L. W. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988; 15: 1833–40
   PubMed Web of Science ®Google Scholar
• Kellgren J. H., Lawrence J. S. Radiological assesment of osteoarthritis. Ann Rheum Dis 1957; 16: 494–501
   PubMed Web of Science ®Google Scholar
• Hart D. J., Spector T. D. Kellgren & Lawrence grade 1 osteophytes in the knee – doubtful or definite?. Osteoarthritis Cartilage 2003; 11: 149–50
   PubMed Web of Science ®Google Scholar
• Dragomir A. D., Kraus V. B., Renner J. B., Luta G., Clark A., Vilim V., et al. Serum cartilage oligomeric matrix protein and clinical signs and symptoms of potential pre‐radiographic hip and knee pathology. Osteoarthritis Cartilage 2002; 10: 687–91
   PubMed Web of Science ®Google Scholar
• Altman R. D. The classification of osteoarthritis. J Rheumatol 1995; 22((Suppl 43))42–3
   Google Scholar